^
    almost3years
    A Study to Evaluate the Safety and Efficacy of ly011 Cell Injection in the Treatment of Advanced Gastric Adenocarcinoma (clinicaltrials.gov)
    P1, N=18, Recruiting, Shanghai Longyao Biotechnology Inc., Ltd.
    New P1 trial
    |
    CLDN18 (Claudin 18)
    |
    LY011
    almost3years
    Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer (clinicaltrials.gov)
    P1, N=30, Recruiting, Shanghai Longyao Biotechnology Inc., Ltd.
    Clinical • New P1 trial • CAR T-Cell Therapy
    |
    CLDN18 (Claudin 18)
    |
    LY011